BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16034562)

  • 1. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.
    Haanen JB; Baars A; Gomez R; Weder P; Smits M; de Gruijl TD; von Blomberg BM; Bloemena E; Scheper RJ; van Ham SM; Pinedo HM; van den Eertwegh AJ
    Cancer Immunol Immunother; 2006 Apr; 55(4):451-8. PubMed ID: 16034562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients.
    Aarntzen EH; Schreibelt G; Bol K; Lesterhuis WJ; Croockewit AJ; de Wilt JH; van Rossum MM; Blokx WA; Jacobs JF; Duiveman-de Boer T; Schuurhuis DH; Mus R; Thielemans K; de Vries IJ; Figdor CG; Punt CJ; Adema GJ
    Clin Cancer Res; 2012 Oct; 18(19):5460-70. PubMed ID: 22896657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients.
    Baars A; Claessen AM; van den Eertwegh AJ; Gall HE; Stam AG; Meijer S; Giaccone G; Meijer CJ; Scheper RJ; Wagstaff J; Vermorken JB; Pinedo HM
    Ann Oncol; 2000 Aug; 11(8):965-70. PubMed ID: 11038032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
    Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
    Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor-infiltrating lymphocytes from human metastatic melanoma].
    Itoh K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2119-26. PubMed ID: 3496855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
    Saberian C; Amaria RN; Najjar AM; Radvanyi LG; Haymaker CL; Forget MA; Bassett RL; Faria SC; Glitza IC; Alvarez E; Parshottam S; Prieto V; Lizée G; Wong MK; McQuade JL; Diab A; Yee C; Tawbi HA; Patel S; Shpall EJ; Davies MA; Hwu P; Bernatchez C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34021033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response in patients with melanoma to immunization using melanoma oncolysates of vaccine virus].
    Doré JF; Portoukalian J; Berthier-Vergnes O; Jacubovich R; Genève J; Bailly M; Lefthériotis E; Weissbrod A; Mayer M
    Bull Cancer; 1990; 77(9):881-91. PubMed ID: 2224160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma.
    Aarntzen EH; Bol K; Schreibelt G; Jacobs JF; Lesterhuis WJ; Van Rossum MM; Adema GJ; Figdor CG; Punt CJ; De Vries IJ
    Cancer Res; 2012 Dec; 72(23):6102-10. PubMed ID: 23010076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic changes in the human skin melanoma after intratumorous treatment with BCG.
    Svejda J; Mechl Z; Sopková B; Foukal T
    Neoplasma; 1979; 26(2):215-21. PubMed ID: 471128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of liposomal tumor antigen vaccines in patients with stage-III melanoma.
    Phillips NC; Loutfi A; A-Kareem AM; Shibata HR; Baines MG
    Cancer Detect Prev; 1990; 14(4):491-6. PubMed ID: 2224912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.
    Lippman SM; Spier CM; Miller TP; Slymen DJ; Rybski JA; Grogan TM
    Mod Pathol; 1990 May; 3(3):361-7. PubMed ID: 2194216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells.
    Berger TG; Haendle I; Schrama D; Lüftl M; Bauer N; Pedersen LØ; Schuler-Thurner B; Hohenberger W; Straten Pt Pt; Schuler G; Becker JC
    Int J Cancer; 2004 Aug; 111(2):229-37. PubMed ID: 15197776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of leukocyte-dependent antibody activity in melanoma patients.
    Hersey P; Edwards A; Murray E; McCarthy WH; Milton GW
    J Natl Cancer Inst; 1983 Jul; 71(1):45-53. PubMed ID: 6575208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy.
    Tjin EP; Konijnenberg D; Krebbers G; Mallo H; Drijfhout JW; Franken KL; van der Horst CM; Bos JD; Nieweg OE; Kroon BB; Haanen JB; Melief CJ; Vyth-Dreese FA; Luiten RM
    Clin Cancer Res; 2011 Sep; 17(17):5736-47. PubMed ID: 21750202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
    Chacon JA; Wu RC; Sukhumalchandra P; Molldrem JJ; Sarnaik A; Pilon-Thomas S; Weber J; Hwu P; Radvanyi L
    PLoS One; 2013; 8(4):e60031. PubMed ID: 23560068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.
    Friedman KM; Prieto PA; Devillier LE; Gross CA; Yang JC; Wunderlich JR; Rosenberg SA; Dudley ME
    J Immunother; 2012 Jun; 35(5):400-8. PubMed ID: 22576345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating K and NK cells in malignant melanoma using monoclonal antibodies].
    Graul A; Orfanos CE
    Z Hautkr; 1985 Feb; 60(4):338-47. PubMed ID: 3984439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases.
    Berd D; Murphy G; Maguire HC; Mastrangelo MJ
    Cancer Res; 1991 May; 51(10):2731-4. PubMed ID: 2021952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T-lymphocytes in the peripheral blood. Study on 113 patients with malignant melanoma].
    Klein R; Krüger GR; Sesterhenn K
    Z Hautkr; 1978 Feb; 53(3):62-6. PubMed ID: 305173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.